Journal Publications

• Turner LW, Kruszewski S, Mojtabai R, Webster D, Nesbit S, Stafford RS, Alexander GC. "Ambulatory Diagnosis and Treatment of Non-Malignant Pain in the United States, 2000-2010." Paper presented at: ISPOR 18th Annual International Meeting; 20 May 2013; New Orleans, Louisiana.
• Turner LW, Kruszewski S, Mojtabai R, Webster D, Nesbit S, Stafford RS, Alexander GC. "Trends in buprenorphine and methadone sales and utilization in the United States, 1997-2012." Paper presented at: ISPOR 18th Annual International Meeting; 20 May 2013; New Orleans, Louisiana
• Alexander GC, Kruszewski SP, Webster DW. "Rethinking Opioid Prescribing to Protect Patient Safety and Public Health". JAMA. 14 Nov 2012. 308(18): 1865-66.
• Kruszewski SP. "Conflicts of Interest". Arch Gen Psychiatry. 2012 Nov; 69(11): 1181-1182.
• Paczynski RP, Alexander GC, Chinchilli VM, Kruszewski SP. "Quality of Evidence in Drug Compendia Supporting Off-Label Use of Typical and Atypical Antipsychotic Medications". International Journal of Risk & Safety in Medicine. 2012; 24(3): 137-146.
• Kruszewski SP, Paczynski RP. "Angst, et al May Have Overlooked a Common Confounding Factor". Archives of General Psychiatry. 6 Oct 2011. [Peer reviewed and published online]
• Kruszewski SP, Paczynski RP. "Re: Dias et al Contectual Encoding in Schizophrenia". Archives of General Psychiatry. 6 Oct 2011. [Peer reviewed and published online]
• Kruszewski SP. "Conflicts of Interest". Journal of the Lancaster General Hospital (LGH), a record of Medical Progress. Fall 2011. Volume 6 No. 3 pp 92-95.
• Kruszewski SP. "Need for Effective Impairment Interventions and Mandated Treatments Extends to Attorneys, Too". American Medical News. 28 Mar 2011. 54(6): 16.
• Paczynski RP, Kruszewski SP. "Transparency needed in psychopharmaceutical trials". Journal of American Physicians and Surgeons. 2009 Winter; 14(4):97.  
• Paczynski RP, Kruszewski SP. "Inadequacies of statutory drug compendia also affect the mental health field". Annals of Internal Medicine. 2009 September 1; 151(5):364-5. 
• Kruszewski SP. Book review: "Doctors of deception". International Journal of Risk & Safety in Medicine. 2009:21(3):171–3.  
• Kruszewski SP, Paczynski RP, Kahn DA. "Gabapentin-induced delirium and dependence: a case report". Journal of Psychiatric Practice. 2009 July; 15(4):314-319. 
• Paczynski RP, Kruszewski SP. "A link between schizophrenia and diabetes?: Insights from the pre-antipsychotic era". International Journal of Risk & Safety in Medicine. 2009:21(3)139-45. 
• Kruszewski SP, Paczynski RP. "Antipsychotic agents and cardiometabolic morbidity in youth". Archives of Pediatrics and Adolescent Medicine. 2009 Apr; 163(4):394-5.
• Paczynski RP, Kruszewski SP. "A link between schizophrenia and diabetes?: Insights from the pre-antipsychotic era". Poster. A-122-0004-00533.Accepted by 5th International Symposium on Diabetes and Pregnancy, Sorrento, Italy. March 26-28, 2009.
• Kruszewski SP, Paczynski RP. "Concomitant use of lorazepam with tamoxifen in bipolar mania clinical trials". Archives of General Psychiatry. 2009 Jan; 66(1):107-8. 
• Kruszewski SP. "Questions for participants at London's conference on doctors' health". [Online Rapid Response to: Doctors' health matters. BMJ2008; 337: a2527] BMJ. 2008 Nov 14; 337:a2527.  
• Kruszewski SP. "Credibility gap revisited". Psychiatric News. August 15 2008; 43(16):23.  
• Kruszewski SP. "Studying placebo effects advance the neuropsychiatric understanding of medical interventions". [Online Rapid Response to: Reclaiming the placebo effect. BMJ. 2008; 336:0] BMJ 2008 May 7; 336:0.
• Kruszewski SP. "A review of "Neurobiology of addiction". American Journal on Addictions. 2008 May: 17(3):254-5.
• Kruszewski SP, Paczynski RP. "Atypical antipsychotic agents for the schizophrenia prodrome: not a clear first choice". International Journal of Risk & Safety in Medicine. 2008 April: 20(1-2):37-44.
• Kruszewski SP, Bialy M, Paczynski RP. "State Medical Board responses to an inquiry on physician researcher misconduct". Journal of Medical Licensure and Discipline.2008; 94(1):16-22.
• Kruszewski SP, Klotz SG."Modafinil: mischaracterizations". Journal of Clinical Psychiatry. 2007 Jun; 68(6): 970-1.  
• Kruszewski SP, Klotz SG. "Open letter to the US FDA". [Online Rapid Response to: Rational prescribing for children. BMJ 332: 1464-1465.] BMJ 2007 Jun 12; 332: 1464-1465.
• Kruszewski SP, Shane JA. "Pregabalin in central neuropathic pain associated with spinal cord injury: A placebo-controlled trial". Neurology. 2007 Jun 12; 68(24):2158-9.  
• Kruszewski SP. "Memorializing our mental health commitment". [Online Rapid Response to: The trouble with US military medicine. BMJ 2007; 334:565] BMJ 2007 May 21; 334:565.  
• Kruszewski SP, Shane, JA. "Efficacy and safety of pramipexole in restless legs syndrome". Neurology 2007 May 8; 68(19):1641-2.
• Kruszewski SP. "Positive psychology". Harvard Magazine. 2007 Mar-Apr; 109(4):4,6.  
• Kruszewski SP. "A personal perspective on the zyprexa documents". [Online Rapid Response to: Lilly investigated in US over the marketing of olanzapine. BMJ 2007; 334:171(27 January), doi:10.1136/bmj.39105.427731.DB]. BMJ 2007 Mar 11; 334: 171-a.
• Kruszewski SP, Klotz SG. "Effects of topiramate". Am J Psychiatry. 2007 Mar; 164(3): 526-7.
• Kruszewski SP, Klotz SG. "Oxcarbazepine adjunctive therapy in infants and young children with partial seizures". Neurology 2007 Feb 06; 68(6):472-3.
• Kruszewski SP. "SSRI informed consent requires full and complete disclosure". [Online Rapid Response to: SSRI use during pregnancy is associated with fetal abnormalities. BMJ 2006; 333:824-d] BMJ 2006 Oct 29; 333: 824-d.
• Kruszewski SP, Shumway KS, Kuhle BX. "Remission of maternal depression and children's psychopathology". JAMA 2006 Sep 13; 296(10):1233. 
• Kruszewski SP, Klotz SG. "Conventional vs. atypical antipsychotic medications". N Engl J Med. 2006 Mar 2; 354(9):972-4.
• Kruszewski SP. "Euphorigenic and abusive properties of modafinil". Am J Psychiatry.2006 Mar; 163(3):549.
• Kruszewski SP, Paczynski RP. "Conclusions inconsistent with results with amphetamines and divalproex". Am J Psychiatry. 2005 Nov; 62(11):2197.
• Kruszewski SP. "Conclusions inconsistent with results with citalopram". Am J Psychiatry. 2005 Nov; 162(11):2195-6.
• Kruszewski SP. "Voices of conscience for healthcare reform". [Online Rapid Response to: How US healthcare cuts could kill me. BMJ 2005; 331: 1030]. BMJ 2005 Oct 31; 331: 1030 #120420.
• Kruszewski SP. "Narrowing the 'credibility gap' ". Psych News 2005 Oct 21; 40(20):29.
• Kruszewski SP. "Why we whistleblowers are passionate in our convictions". PLoS Med. 2005 Aug;2(8):e281.
• Kruszewski SP. "The timing of published non-confirmatory data re-analysis deserves attention". [Online Rapid Response to: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005; 331:321-327.] BMJ 2005 Aug 16; 331:321-327
• Kruszewski SP. "The American Medical Association's response to pharmaceutical advertising". [Online Rapid Response to: American Medical Association rejects proposal to bad consumer adverts for prescription medicines. BMJ 2005; 331:7-a.] BMJ 2005 Jul 06; 331: 7-#111436.
• Kruszewski SP. "Schizophrenia and epilepsy: untenable link from flawed research design". [Online Rapid Response to: Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 2005; 331: 23]. BMJ .2005 Jul 05; 331:23.
• Kruszewski SP. "HIV/AIDS demographics similar in Dauphin County, Pennsylvania USA". [Online Rapid Response to: Treatment exhaustion of highly active antiretroviral therapy (HARRT) among individuals infected with HIV in the United Kingdom: multicentre cohort study. BMJ 2005: 330: 695.]. BMJ 2005 Mar 29; 330:695 #101837.
• Kruszewski SP. "HIV/AIDS demographics in US county and southeast England are similar". BMJ. 2005 May 21; 330(7501):1209-10. http://www.bmj.com/content/330/7501/1209.3
• Kruszewski SP. "Disingenuous remarks from the AMA on tort reform". [Online Rapid Response to: Bush signs act that requires class action suits in state courts. BMJ 2005; 330:499-c]. BMJ 2005 Mar 05; 330: 499-c #99230.
• Kruszewski SP. "Neonatal brain injury". N Engl J Med. 2005 Feb 24; 352(8):839.
• Kruszewski SP. "Protecting editorial integrity through responsibility and resolve". [Online Rapid Response to: A tough nut to crack. BMJ 2005; 330: 0-h.]. BMJ 2005 Feb 05; 330: 0-h #95621.
• Kruszewski SP. "Aetiology and pathophysiology exist in DSM-IV". [Online Rapid Response to: Rationale for psychostimulants in ADHD. BMJ 2005; 330:95-b]. BMJ 2005 Jan 10; 330: 95-b.
• Kruszewski SP. "Published conclusions must accurately reflect research results". [Online Rapid Response to: Trial Results: the next battle. BMJ 2005; 330-g]. BMJ 2005 Jan 19; 330: 0-g.
• Kruszewski SP. "Imputation sequences in cannabis study". [Online Rapid Response to: Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.BMJ 2004; 0: bmj.38267.664086.63v1.] BMJ. 2004 Dec 12; 0:bmj.38267.664086.63vl.
• Kruszewski SP. "Scientific credibility is based upon transparent debate". [Online Rapid Response to: Is drug regulation failing? BMJ 2004; 329: 0-g] BMJ. 2004 Dec 4; 329:0-g.
• Kruszewski SP. "Politicized psychopharmacological debate". Am Soc Adolesc Psych Newsletter. 2004 Winter: 11.
• Kruszewski SP. "The inseparability of medicine and politics". [Online Rapid Response to: Should journals mix medicine and politics? BMJ 329: 0-g]. BMJ. 2004 Nov 10; 329:0-g
• Kruszewski SP. "The influence of TMAP: mandatory mental health evaluations". Under Reported. Independent Media TV publishing 2004 Oct 04.
• Kruszewski SP. "APA at odds with FDA advisory panel". [Online Rapid Response to: FDA panel urges "black box" warning for antidepressants. BMJ 2004; 329: 702]. BMJ 2004 Sep 25; 329: 702 #75714.
• Mardon RE, Sampsel SL, Gwet P, Kruszewski SP. "Access to behavioral health services: visit timeliness: field test report". National Committee for Quality Assurance, Washington, DC. 2003 Dec 11: 1-15.
• Kruszewski SP. "Recovery and relapse: opposing directions on the same road". PHP Update, The Foundation of the Pennsylvania Medical Society 2002; 40: 1-2.
• Kruszewski SP. "Approach to depressive disorders". Arch Fam Med. 2000 Jan; 9(1):19.
• Kruszewski SP. "Valproate-induced carbamazepine toxicity causing death". Ann Clin Psych. 1999 Sep; 11(3):170-1
• Kruszewski SP. "Tobacco litigation". N Engl J Med. 1997 Jun 19; 336(25):1833-4.
• Habashi M, Kruszewski SP. "Lead encephalopathy from inhalation of leaded gases in an adult". Clinical Research 1997; 35(3):743A.
• Kruszewski SP. "Faith in psychiatry". Clinical Psychiatry News. 1993 Dec: 22-3.
• Zimmer B, Price TRP, Garber HJ, Kruszewski SP, Mazur R. "Poster: Bupropion use in patients at risk for seizures". American Psychiatric Association [Poster-paper] 1992 May
• Kruszewski SP, Zimmer B. "The Charles Bonnet Syndrome: description in search of etiology". Neuroscience Journal, Allegheny General Hospital 1992; 3(1);29-33.
• Kruszewski SP, Long S. "Frontal lobe pathology: questions of attribution and discovery". Neuroscience Journal, Allegheny General Hospital. 1992; 3(1):23-8.
• Kruszewski SP, Zimmer B. "The Charles Bonnet Syndrome Revisited".American Association of Geriatric Psychiatry. Paper presented in San Francisco, California 1992 Feb 14.
• Kruszewski SP. "Familial subtyping of depression: a re-examination of the endocrine, clinical and hereditary subgroup date in affective disorders". Res Comm Psychol Psychiatr Behav. 1983; 8(2):207-221.
• Kruszewski SP, Goldstein L. "Sensory input processing: differences between depressed, schizophrenic and normal subjects". Adv Biol Psychiatry. 1983; 13:49-53.
• Goldstein L, Kruszewski SP, Swartzburg M, Krawciw N. "Computerized hemispheric EEG, clinical and endocrinological data in depressed patients". Second International Conference on Laterality and Psychopathology 1982. [Banff. Alberta, Canada.]
• Kruszewski SP, Jacobs WT. "Polarity of thiamine movement through tomato petioles". Plant Physiol.1974 Sep; 54(3):310-11.